Get Ready To Deliver What's Next With The Sefia™ Cell Therapy Manufacturing Platform

The Sefia™ platform serves as a comprehensive, end-to-end solution designed to streamline the complex workflow of CAR T cell therapy manufacturing. Tailored specifically for cell therapy manufacturers, this platform integrates two specialized systems that automate critical stages of the production process. The Sefia Select™ system is responsible for automating the early phases, including cell isolation, harvest, and formulation, ensuring consistency and efficiency from the outset. Complementing this, the Sefia Expansion system takes over the subsequent stages, automating cell activation, transduction, and expansion to support robust and scalable cell growth. Together, these systems create a seamless and efficient manufacturing pipeline—from the initial patient sample to the final therapeutic doses—empowering manufacturers to deliver high-quality cell therapies with greater speed, precision, and reliability.